'Roche could've earned over 100 times what it cost for...

Dununu.com Dununu

Sponsorizzato

'Roche could've earned over 100 times what it cost for rare disease drug'

RSS Feed National

Posted

135

Public health activists estimate Roche earned significantly more from risdiplam, a spinal muscular atrophy drug, than its development costs. Roche disputes this, citing expenses from unsuccessful projects and ongoing research. While the drug remains unaffordable for many in India, Roche offers access programs and free treatment to some patients.

Read Full Article

Effettua l'accesso per mettere mi piace, condividere e commentare!

'Something I can turn to, somebody I can kiss': Astronomer CEO, HR head spotted kissing at Coldplay concert; Andy Byron sent on leave

Astronomer CEO Andy Byron and HR head Kristin Cabot were caught on camera sharing an intimate...

By 0 0

When Trump called Murdoch legendary: Old clips of US President praising media giant go viral after lawsuit - watch

Donald Trump has filed a $10 billion defamation lawsuit against Rupert Murdoch. This follows a...

By 0 0

'Years of friendship and huglomacy': Congress slams PM Modi over Trump's 'jets shot down' claims; asks why nation's honour was compromised for trade

By 0 5

Exclusive | 'All good things come to an end': Williamson on Kohli's retirement

Kane Williamson, in an exclusive interview, lauded Shubman Gill's captaincy, stating it was no...

By 0 3

Russia oil sanctions: EU moves on crude, oil price cap may hit Reliance, Nayara; enforcing may be difficult, India may still benefit

New EU sanctions on Russian oil pose challenges for Indian giants Nayara Energy and Reliance...

By 0 8